• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The t(8;13) atypical myeloproliferative disorder: further analysis of the ZNF198 gene and lack of evidence for multiple genes disrupted on chromosome 13.

作者信息

Still I H, Cowell J K

出版信息

Blood. 1998 Aug 15;92(4):1456-8.

PMID:9694738
Abstract
摘要

相似文献

1
The t(8;13) atypical myeloproliferative disorder: further analysis of the ZNF198 gene and lack of evidence for multiple genes disrupted on chromosome 13.
Blood. 1998 Aug 15;92(4):1456-8.
2
Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome.在t(8;13)(p11;q12)骨髓增殖综合征中ZNF198与成纤维细胞生长因子受体-1的持续融合。
Blood. 1998 Sep 1;92(5):1735-42.
3
A further case of myeloproliferative syndrome with reciprocal translocation (8;13)(p11;q12).一例伴有相互易位（8；13）（p11；q12）的骨髓增殖综合征病例。
Haematologica. 2004 Feb;89(2):239-41.
4
The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP.与一种非典型骨髓增殖性疾病相关的t(8;13)(p11;q11 - 12)重排，将成纤维细胞生长因子受体1基因与一个新基因RAMP融合。
Hum Mol Genet. 1998 Apr;7(4):637-42. doi: 10.1093/hmg/7.4.637.
5
FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome.在t(8;13)白血病/淋巴瘤综合征中，成纤维细胞生长因子受体1（FGFR1）与一种新的锌指基因ZNF198发生融合。
Nat Genet. 1998 Jan;18(1):84-7. doi: 10.1038/ng0198-84.
6
A rare case report of 8p11 myeloid and lymphoid neoplasm with FGFR1 abnormality in a young adult.一名年轻成年人中伴有FGFR1异常的8p11髓系和淋巴系肿瘤的罕见病例报告。
Ann Hematol. 2013 Jan;92(2):285-6. doi: 10.1007/s00277-012-1562-7. Epub 2012 Sep 2.
7
Combined translocation with ZNF198-FGFR1 gene fusion and deletion of potential tumor suppressors in a myeloproliferative disorder.骨髓增殖性疾病中伴有ZNF198-FGFR1基因融合的联合易位及潜在肿瘤抑制基因的缺失
Cancer Genet Cytogenet. 2007 Mar;173(2):154-8. doi: 10.1016/j.cancergencyto.2006.10.004.
8
Characterization of FIM-FGFR1, the fusion product of the myeloproliferative disorder-associated t(8;13) translocation.骨髓增殖性疾病相关的t(8;13)易位融合产物FIM-FGFR1的特征分析
J Biol Chem. 1999 Sep 17;274(38):26922-30. doi: 10.1074/jbc.274.38.26922.
9
Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL.在一种骨髓增殖性疾病中，由于t(8;22)(p11;q11)导致的BCR与成纤维细胞生长因子受体1（FGFR1）基因融合：首个涉及BCR但不涉及ABL的融合基因。
Genes Chromosomes Cancer. 2001 Dec;32(4):302-10. doi: 10.1002/gcc.1195.
10
The 8p12 myeloproliferative disorder. t(8;19)(p12;q13.3): a novel translocation involving the FGFR1 gene.
Br J Haematol. 2000 Nov;111(2):647-9. doi: 10.1046/j.1365-2141.2000.02355.x.

引用本文的文献

1
Novel mutation c.2090_2091del in neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities in an 18.5-mo-old boy: A case report.一名18.5个月大男童患神经发育-颅面综合征伴可变肾脏和心脏异常，存在新型突变c.2090_2091del：病例报告
World J Clin Cases. 2023 Jun 6;11(16):3891-3898. doi: 10.12998/wjcc.v11.i16.3891.
2
The 8p11 myeloproliferative syndrome: Genotypic and phenotypic classification and targeted therapy.8p11骨髓增殖综合征：基因型和表型分类及靶向治疗。
Front Oncol. 2022 Nov 3;12:1015792. doi: 10.3389/fonc.2022.1015792. eCollection 2022.
3
A truncated derivative of FGFR1 kinase cooperates with FLT3 and KIT to transform hematopoietic stem cells in syndromic and de novo AML.
FGFR1 激酶的截断衍生物与 FLT3 和 KIT 合作，在综合征和新发 AML 中转化造血干细胞。
Mol Cancer. 2022 Jul 29;21(1):156. doi: 10.1186/s12943-022-01628-3.
4
Mechanisms of resistance to FGFR1 inhibitors in FGFR1-driven leukemias and lymphomas: implications for optimized treatment.FGFR1驱动的白血病和淋巴瘤中对FGFR1抑制剂耐药的机制：对优化治疗的启示
Cancer Drug Resist. 2021;4(3):607-619. doi: 10.20517/cdr.2021.30. Epub 2021 May 25.
5
Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations.转录核心抑制因子 ZMYM2 的突变导致综合征性泌尿道畸形。
Am J Hum Genet. 2020 Oct 1;107(4):727-742. doi: 10.1016/j.ajhg.2020.08.013. Epub 2020 Sep 4.
6
Mutation in the FGFR1 tyrosine kinase domain or inactivation of PTEN is associated with acquired resistance to FGFR inhibitors in FGFR1-driven leukemia/lymphomas.FGFR1酪氨酸激酶结构域的突变或PTEN的失活与FGFR1驱动的白血病/淋巴瘤中对FGFR抑制剂的获得性耐药有关。
Int J Cancer. 2017 Nov 1;141(9):1822-1829. doi: 10.1002/ijc.30848. Epub 2017 Jul 28.
7
Development of ZMYM2-FGFR1 driven AML in human CD34+ cells in immunocompromised mice.在免疫缺陷小鼠的人CD34+细胞中ZMYM2-FGFR1驱动的急性髓系白血病的发展
Int J Cancer. 2016 Aug 15;139(4):836-40. doi: 10.1002/ijc.30100. Epub 2016 May 4.
8
Constitutive Notch pathway activation in murine ZMYM2-FGFR1-induced T-cell lymphomas associated with atypical myeloproliferative disease.ZMYM2-FGFR1 诱导的小鼠 T 细胞淋巴瘤中组成性 Notch 通路激活与非典型骨髓增生性疾病相关。
Blood. 2011 Jun 23;117(25):6837-47. doi: 10.1182/blood-2010-07-295725. Epub 2011 Apr 28.
9
Phosphorylation of the SSBP2 and ABL proteins by the ZNF198-FGFR1 fusion kinase seen in atypical myeloproliferative disorders as revealed by phosphopeptide-specific MS.磷酸肽特异性质谱分析显示，在非典型骨髓增殖性疾病中可见ZNF198 - FGFR1融合激酶对SSBP2和ABL蛋白进行磷酸化。
Proteomics. 2009 Aug;9(16):3979-88. doi: 10.1002/pmic.200800852.
10
Genetic fingerprinting of the development and progression of T-cell lymphoma in a murine model of atypical myeloproliferative disorder initiated by the ZNF198-fibroblast growth factor receptor-1 chimeric tyrosine kinase.在由ZNF198-成纤维细胞生长因子受体-1嵌合酪氨酸激酶引发的非典型骨髓增殖性疾病小鼠模型中，T细胞淋巴瘤发生发展的基因指纹分析
Blood. 2009 Aug 20;114(8):1576-84. doi: 10.1182/blood-2009-03-212704. Epub 2009 Jun 8.